Proposals for managing patients with thoracic malignancies during COVID-19 pandemic

The objective of this document is to formalize a degraded mode management for patients with thoracic cancers in the context of the COVID-19 pandemic The proposals are based on those of the French High Council for Public Health, on published data outside the context of COVID-19, and on a concerted analysis of the risk-benefit ratio for our patients by a panel of experts specialized on thoracic oncology under the aegis of the French-Language Society of Pulmonology (SPLF) / French-language oncology group These proposals are evolving (10/04/2020) according to the situations encountered which will enrich it, and are to be adapted to our institutional organisations and to the evolution of resources during the COVID-19 epidemic Patients with symptoms and/or COVID-19+ are not discussed in this document and are managed within the framework of specific channels